Chugai’s Appeal Bid for Edirol Method-of-Use Patent Dismissed

Japan’s Intellectual Property High Court on December 13 turned down Chugai Pharmaceutical’s appeal over a lower-court ruling that rejected its claim for the method-of-use patent of its osteoporosis treatment Edirol (eldecalcitol). “We will consider future measures based on the contents...read more